Vascular dysfunction in Alzheimer's disease: a biomarker of disease progression and a potential therapeutic target

被引：16
|
作者：
Govindpani, Karan [1 ]
Vinnakota, Chitra [1 ]
Waldvogel, Henry J. [1 ]
Faull, Richard L. [1 ]
Kwakowsky, Andrea [1 ]
机构：
[1] Univ Auckland, Dept Anat & Med Imaging, Ctr Brain Res, Fac Med & Hlth Sci, Auckland, New Zealand
来源：
NEURAL REGENERATION RESEARCH | 2020年 / 15卷 / 06期
关键词：
BRAIN;
D O I：
10.4103/1673-5374.270306
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
[No abstract available]
引用
收藏
页码：1030 / 1032
页数：3
相关论文
共 50 条
  • [21] Dysfunction of axonal transport in normal-tension glaucoma:a biomarker of disease progression and a potential therapeutic target
    Kazuyuki Hirooka
    Tohru Yamamoto
    Yoshiaki Kiuchi
    Neural Regeneration Research, 2021, 16 (03) : 506 - 507
  • [22] Mitochondrial dysfunction in lymphocytes - a potential biomarker for Alzheimer's disease
    Leuner, K.
    Pantel, J.
    Schulz, K.
    Schuett, T.
    Lipka, U.
    Eckert, A.
    Mueller, W. E.
    PHARMACOPSYCHIATRY, 2009, 42 (05) : 229 - 229
  • [23] Arrestin' Alzheimer disease progression? β-arrestin 2 is a potential therapeutic target
    Heather Wood
    Nature Reviews Neurology, 2013, 9 (2) : 60 - 60
  • [24] YKL-40 as a Potential Biomarker and a Possible Target in Therapeutic Strategies of Alzheimer's Disease
    Muszynski, Pawel
    Groblewska, Magdalena
    Kulczynska-Przybik, Agnieszka
    Kulakowska, Alina
    Mroczko, Barbara
    CURRENT NEUROPHARMACOLOGY, 2017, 15 (06) : 906 - 917
  • [25] A2A Adenosine Receptor as a Potential Biomarker and a Possible Therapeutic Target in Alzheimer's Disease
    Gessi, Stefania
    Poloni, Tino Emanuele
    Negro, Giulia
    Varani, Katia
    Pasquini, Silvia
    Vincenzi, Fabrizio
    Borea, Pier Andrea
    Merighi, Stefania
    CELLS, 2021, 10 (09)
  • [26] Epigenetic regulation in Alzheimer's disease: is it a potential therapeutic target?
    Coppede, Fabio
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2021, 25 (04) : 283 - 298
  • [27] Noradrenaline in Alzheimer's Disease: A New Potential Therapeutic Target
    Gutierrez, Irene L.
    Dello Russo, Cinzia
    Novellino, Fabiana
    Caso, Javier R.
    Garcia-Bueno, Borja
    Leza, Juan C.
    Madrigal, Jose L. M.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (11)
  • [28] Amylin Receptor: A Potential Therapeutic Target for Alzheimer's Disease
    Fu, Wen
    Patel, Aarti
    Kimura, Ryoichi
    Soudy, Rania
    Jhamandas, Jack H.
    TRENDS IN MOLECULAR MEDICINE, 2017, 23 (08) : 709 - 720
  • [29] Vascular α1A Adrenergic Receptors as a Potential Therapeutic Target for IPAD in Alzheimer's Disease
    Frost, Miles
    Keable, Abby
    Baseley, Dan
    Sealy, Amber
    Zbarcea, Diana Andreea
    Gatherer, Maureen
    Yuen, Ho Ming
    Sharp, Matt MacGregor
    Weller, Roy O.
    Attems, Johannes
    Smith, Colin
    Chiarot, Paul R.
    Carare, Roxana O.
    PHARMACEUTICALS, 2020, 13 (09) : 1 - 14
  • [30] Potential Roles of α-amylase in Alzheimer's Disease: Biomarker and Drug Target
    Chen, Win Ning
    Tang, Kim San
    Yeong, Keng Yoon
    CURRENT NEUROPHARMACOLOGY, 2022, 20 (08) : 1554 - 1563
12345